Atlas Trials

Guangzhou JOYO Pharma Co., Ltd

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Guangzhou JOYO Pharma Co., Ltd

RecordFirmDate
JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs. (NCT07154368)Guangzhou JOYO Pharma Co., Ltd2025-09-23
Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS (NCT06895031)Guangzhou JOYO Pharma Co., Ltd2025-03-31
A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis (NCT06158490)Guangzhou JOYO Pharma Co., Ltd2023-12-27
Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects (NCT06135363)Guangzhou JOYO Pharma Co., Ltd2022-08-11
Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults. (NCT06137911)Guangzhou JOYO Pharma Co., Ltd2021-09-26
The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects. (NCT06160440)Guangzhou JOYO Pharma Co., Ltd2021-06-03
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolemic (NCT04927221)Guangzhou JOYO Pharma Co., Ltd2021-04-01
Evaluation of Safety, Tolerability, PK/PD, and Metabolism of Single-Dose Singletine(DC407) in Adults (NCT06160401)Guangzhou JOYO Pharma Co., Ltd2020-08-18

Track Guangzhou JOYO Pharma Co., Ltd automatically

Every clearance here is in the API, with alerts when new ones post.